|
1
|
Deorah S, Lynch CF, Sibenaller ZA and
Ryken TC: Trends in brain cancer incidence and survival in the
United States: Surveillance, Epidemiology, and End Results Program,
1973 to 2001. Neurosurg Focus. 20:E12006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Reardon DA, Herndon JE II, Peters KB,
Desjardins A, Coan A, Lou E, Sumrall AL, Turner S, Lipp ES,
Sathornsumetee S, et al: Bevacizumab continuation beyond initial
bevacizumab progression among recurrent glioblastoma patients. Br J
Cancer. 107:1481–1487. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bertling E, Hotulainen P, Mattila PK,
Matilainen T, Salminen M and Lappalainen P: Cyclase-associated
protein 1 (CAP1) promotes cofilin-induced actin dynamics in
mammalian nonmuscle cells. Mol Biol Cell. 15:2324–2334. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Maher EA, Furnari FB, Bachoo RM, Rowitch
DH, Louis DN, Cavenee WK and DePinho RA: Malignant glioma: Genetics
and biology of a grave matter. Genes Dev. 15:1311–1333. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhuang W, Qin Z and Liang Z: The role of
autophagy in sensitizing malignant glioma cells to radiation
therapy. Acta Biochim Biophys Sin (Shanghai). 41:341–351. 2009.
View Article : Google Scholar
|
|
6
|
Wen PY and Kesari S: Malignant gliomas in
adults. N Engl J Med. 359:492–507. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cohen PT: Protein phosphatase 1 - targeted
in many directions. J Cell Sci. 115:241–256. 2002.PubMed/NCBI
|
|
8
|
Varmuza S, Jurisicova A, Okano K, Hudson
J, Boekelheide K and Shipp EB: Spermiogenesis is impaired in mice
bearing a targeted mutation in the protein phosphatase 1cgamma
gene. Dev Biol. 205:98–110. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bargou RC, Emmerich F, Krappmann D,
Bommert K, Mapara MY, Arnold W, Royer HD, Grinstein E, Greiner A,
Scheidereit C, et al: Constitutive nuclear factor-kappaB-RelA
activation is required for proliferation and survival of Hodgkin's
disease tumor cells. J Clin Invest. 100:2961–2969. 1997. View Article : Google Scholar
|
|
10
|
Borrello MG, Degl'Innocenti D and Pierotti
MA: Inflammation and cancer: The oncogene-driven connection. Cancer
Lett. 267:262–270. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Opaluch AM, Schneider M, Chiang CY, Nguyen
QT, Maestre AM, Mulder LC, Secundino I, De Jesus PD, König R, Simon
V, et al: Positive regulation of TRAF6-dependent innate immune
responses by protein phosphatase PP1-γ. PLoS One. 9:e892842014.
View Article : Google Scholar
|
|
12
|
Ang E, Pavlos NJ, Rea SL, Qi M, Chai T,
Walsh JP, Ratajczak T, Zheng MH and Xu J: Proteasome inhibitors
impair RANKL-induced NF-kappaB activity in osteoclast-like cells
via disruption of p62, TRAF6, CYLD, and IkappaBalpha signaling
cascades. J Cell Physiol. 220:450–459. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang Y, Blair HC, Shapiro IM and Wang B:
The proteasome inhibitor carfilzomib suppresses parathyroid
hormone-induced osteoclastogenesis through a RANKL-mediated
signaling pathway. J Biol Chem. 290:16918–16928. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Vallabhapurapu S and Karin M: Regulation
and function of NF-kappaB transcription factors in the immune
system. Annu Rev Immunol. 27:693–733. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bettoun DJ, Buck DW II, Lu J, Khalifa B,
Chin WW and Nagpal S: A vitamin D receptor-Ser/Thr phosphatase-p70
S6 kinase complex and modulation of its enzymatic activities by the
ligand. J Biol Chem. 277:24847–24850. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang Y, Liu F, Mao F, Hang Q, Huang X, He
S, Wang Y, Cheng C, Wang H, Xu G, et al: Interaction with cyclin
H/cyclin-dependent kinase 7 (CCNH/CDK7) stabilizes C-terminal
binding protein 2 (CtBP2) and promotes cancer cell migration. J
Biol Chem. 288:9028–9034. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tao T, Cheng C, Ji Y, Xu G, Zhang J, Zhang
L and Shen A: Numbl inhibits glioma cell migration and invasion by
suppressing TRAF5-mediated NF-κB activation. Mol Biol Cell.
23:2635–2644. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huang X, Liu F, Zhu C, Cai J, Wang H, Wang
X, He S, Liu C, Yao L, Ding Z, et al: Suppression of KIF3B
expression inhibits human hepatocellular carcinoma proliferation.
Dig Dis Sci. 59:795–806. 2014. View Article : Google Scholar :
|
|
19
|
Ding Z, Liu X, Liu Y, Zhang J, Huang X,
Yang X, Yao L, Cui G and Wang D: Expression of far upstream element
(FUSE) binding protein 1 in human glioma is correlated with c-Myc
and cell proliferation. Mol Carcinog. 54:405–415. 2015. View Article : Google Scholar
|
|
20
|
Lin SY, Makino K, Xia W, Matin A, Wen Y,
Kwong KY, Bourguignon L and Hung MC: Nuclear localization of EGF
receptor and its potential new role as a transcription factor. Nat
Cell Biol. 3:802–808. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Giri DK, Ali-Seyed M, Li LY, Lee DF, Ling
P, Bartholomeusz G, Wang SC and Hung MC: Endosomal transport of
ErbB-2: Mechanism for nuclear entry of the cell surface receptor.
Mol Cell Biol. 25:11005–11018. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu Y, Wang Y, Cheng C, Chen Y, Shi S, Qin
J, Xiao F, Zhou D, Lu M, Lu Q, et al: A relationship between p27
(kip1) and Skp2 after adult brain injury: Implications for glial
proliferation. J Neurotrauma. 27:361–371. 2010. View Article : Google Scholar
|
|
23
|
Ahn KS, Sethi G and Aggarwal BB: Nuclear
factor-kappa B: From clone to clinic. Curr Mol Med. 7:619–637.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ferguson SD: Malignant gliomas: Diagnosis
and treatment. Dis Mon. 57:558–569. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Stupp R, Hegi ME, van den Bent MJ, Mason
WP, Weller M, Mirimanoff RO and Cairncross JG; European
Organisation for Research and Treatment of Cancer Brain Tumor and
Radiotherapy Groups; National Cancer Institute of Canada Clinical
Trials Group: Changing paradigms - an update on the
multidisciplinary management of malignant glioma. Oncologist.
11:165–180. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Qi S, Song Y, Peng Y, Wang H, Long H, Yu
X, Li Z, Fang L, Wu A, Luo W, et al: ZEB2 mediates multiple
pathways regulating cell proliferation, migration, invasion, and
apoptosis in glioma. PLoS One. 7:e388422012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lee JH, You J, Dobrota E and Skalnik DG:
Identification and characterization of a novel human PP1
phosphatase complex. J Biol Chem. 285:24466–24476. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Virshup DM and Shenolikar S: From
promiscuity to precision: Protein phosphatases get a makeover. Mol
Cell. 33:537–545. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lin CY, Tan BC, Liu H, Shih CJ, Chien KY,
Lin CL and Yung BY: Dephosphorylation of nucleophosmin by PP1β
facilitates pRB binding and consequent E2F1-dependent DNA repair.
Mol Biol Cell. 21:4409–4417. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li HY, Liu H, Wang CH, Zhang JY, Man JH,
Gao YF, Zhang PJ, Li WH, Zhao J, Pan X, et al: Deactivation of the
kinase IKK by CUEDC2 through recruitment of the phosphatase PP1.
Nat Immunol. 9:533–541. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Olsen JV, Vermeulen M, Santamaria A, Kumar
C, Miller ML, Jensen LJ, Gnad F, Cox J, Jensen TS, Nigg EA, et al:
Quantitative phosphoproteomics reveals widespread full
phosphorylation site occupancy during mitosis. Sci Signal.
3:ra32010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Radner H, Blümcke I, Reifenberger G and
Wiestler OD: The new WHO classification of tumors of the nervous
system 2000. Pathology and genetics. Pathologe. 23:260–283. 2002.In
German. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ahn KS and Aggarwal BB: Transcription
factor NF-kappaB: A sensor for smoke and stress signals. Ann NY
Acad Sci. 1056:218–233. 2005. View Article : Google Scholar
|
